Table 3.
Distribution of ESBLs and MBLs producing isolates among clinical specimens.
| Type of Infection | β-Lactam Resistant Isolates | ESBLs | MBL | ||
|---|---|---|---|---|---|
| No. | % * | No. | % * | ||
| Wound infections | 25 | 25 | 100% | 12 | 48% |
| Urinary tract infection | 28 | 28 | 100% | 20 | 71.4% |
| Gastro-enteritis | 15 | 5 | 33.3% | 0 | 0% |
| Blood | 20 | 20 | 100% | 12 | 46.67% |
| Respiratory infection | 4 | 4 | 100% | 2 | 50% |
| Ear infection | 2 | 2 | 100% | 1 | 50% |
| Eye | 1 | 1 | 100% | 1 | 100% |
| Total | 95 | 85 | 89.4% ** | 48 | 50.5% ** |
* percent was correlated to the total number of samples of each infection type; ** percent was correlated to total number of samples. Significant if p ≤ 0.05.